ChineseInvestors.com, Inc. (OTCQB: CIIX) attended the ‘Invest 2017’ exhibition in Stuttgart, Germany, on April 7-8, 2017, anticipating that the conference would be an opportunity for CIIX to introduce its hemp companies and products to German investors, but CIIX is not alone in seeing the growth opportunities for medical cannabis in that market. CIIX operates a website for Chinese-speaking investors. It has also opened, in the Shanghai Free Trade Area, a store that distributes CBD health oil products to the global Chinese-speaking population.
Germany permits the use of medical marijuana, and it recently further loosened its regulations. Earlier this year, the country legalized medical cannabis, but it has tightly limited its prescriptions to individuals with illnesses such as chronic pain, nausea related to cancer treatments, multiple sclerosis, and epilepsy.
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has established a special marijuana agency to control the distribution of medical marijuana. The agency will oversee the cultivation and distribution of marijuana in that country. Berlin plans to have its own program by 2019 to grow cannabis at home, and the German government will solicit bids from EU countries to operate the cultivation process. Germany says it will work to ensure that only pharmaceutical grade hemp should reach patients, as noted by Lutz Stroppe, State Secretary of the Federal Ministry of Health.
CIIX sees an opportunity to participate in the German market, and it is also targeting expansion within China and throughout North America and Asia. The ‘Invest 2017’ conference was a chance to showcase the company’s hemp-based product line to the German financial community.
For more information, visit the company’s website at www.ChineseInvestors.com
Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board